Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Long-term persistence of BCG Pasteur in lungs of C57BL/6 mice following intranasal infection.

Leversen NA, Sviland L, Wiker HG, Mustafa T.

Scand J Immunol. 2012 May;75(5):489-99. doi: 10.1111/j.1365-3083.2012.02683.x.

2.

Intranasal bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology.

Tree JA, Williams A, Clark S, Hall G, Marsh PD, Ivanyi J.

Clin Exp Immunol. 2004 Dec;138(3):405-9.

3.

Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.

Kohama H, Umemura M, Okamoto Y, Yahagi A, Goga H, Harakuni T, Matsuzaki G, Arakawa T.

Vaccine. 2008 Feb 13;26(7):924-32. doi: 10.1016/j.vaccine.2007.12.005. Epub 2007 Dec 26.

PMID:
18192091
4.

Characterization of lung gamma delta T cells following intranasal infection with Mycobacterium bovis bacillus Calmette-Guérin.

Dieli F, Ivanyi J, Marsh P, Williams A, Naylor I, Sireci G, Caccamo N, Di Sano C, Salerno A.

J Immunol. 2003 Jan 1;170(1):463-9.

5.

Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system.

Majlessi L, Brodin P, Brosch R, Rojas MJ, Khun H, Huerre M, Cole ST, Leclerc C.

J Immunol. 2005 Mar 15;174(6):3570-9.

6.

Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains.

Lagranderie MR, Balazuc AM, Deriaud E, Leclerc CD, Gheorghiu M.

Infect Immun. 1996 Jan;64(1):1-9.

7.

Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells.

Demangel C, Bean AG, Martin E, Feng CG, Kamath AT, Britton WJ.

Eur J Immunol. 1999 Jun;29(6):1972-9.

8.

Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group.

Lozes E, Denis O, Drowart A, Jurion F, Palfliet K, Vanonckelen A, De Bruyn J, De Cock M, Van Vooren JP, Huygen K.

Scand J Immunol. 1997 Jul;46(1):16-26.

9.

Strain-specific differences in the genetic control of two closely related mycobacteria.

Di Pietrantonio T, Hernandez C, Girard M, Verville A, Orlova M, Belley A, Behr MA, Loredo-Osti JC, Schurr E.

PLoS Pathog. 2010 Oct 28;6(10):e1001169. doi: 10.1371/journal.ppat.1001169.

10.

Divergence of immunologic and protective responses of different BCG strains in a murine model.

Kozak R, Behr MA.

Vaccine. 2011 Feb 4;29(7):1519-26. doi: 10.1016/j.vaccine.2010.12.012. Epub 2010 Dec 22.

PMID:
21184855
11.

A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice.

Wang C, Chen Z, Fu R, Zhang Y, Chen L, Huang L, Li J, Shi C, Fan X.

Med Microbiol Immunol. 2011 Aug;200(3):165-75. doi: 10.1007/s00430-011-0188-z. Epub 2011 Feb 22.

PMID:
21340709
12.

Immunization of mice after airborne infection with various strains of BCG.

Lefford MJ.

Am Rev Respir Dis. 1978 Jan;117(1):103-9.

PMID:
339795
13.

Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells.

Ordway DJ, Shang S, Henao-Tamayo M, Obregon-Henao A, Nold L, Caraway M, Shanley CA, Basaraba RJ, Duncan CG, Orme IM.

Clin Vaccine Immunol. 2011 Sep;18(9):1527-35. doi: 10.1128/CVI.05127-11. Epub 2011 Jul 27.

14.
15.

Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.

Quinn KM, Rich FJ, Goldsack LM, de Lisle GW, Buddle BM, Delahunt B, Kirman JR.

Eur J Immunol. 2008 Mar;38(3):695-705. doi: 10.1002/eji.200737888.

16.

Intranasal BCG vaccination protects BALB/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs.

Lyadova IV, Vordermeier HM, Eruslanov EB, Khaidukov SV, Apt AS, Hewinson RG.

Clin Exp Immunol. 2001 Nov;126(2):274-9.

17.

An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.

Dieli F, Taniguchi M, Kronenberg M, Sidobre S, Ivanyi J, Fattorini L, Iona E, Orefici G, De Leo G, Russo D, Caccamo N, Sireci G, Di Sano C, Salerno A.

J Immunol. 2003 Aug 15;171(4):1961-8.

18.
19.

Immune response induced by three Mycobacterium bovis BCG substrains with diverse regions of deletion in a C57BL/6 mouse model.

Irwin SM, Goodyear A, Keyser A, Christensen R, Troudt JM, Taylor JL, Bohsali A, Briken V, Izzo AA.

Clin Vaccine Immunol. 2008 May;15(5):750-6. doi: 10.1128/CVI.00018-08. Epub 2008 Mar 19.

Supplemental Content

Support Center